Bill Miller
Miller Value Partners
Bill Miller Bristol-Myers Squibb Company stake
total: 463
Miller Value Partners BMY trades
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2024 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q2 report, Bill Miller holds 69,500 Bristol-Myers Squibb Company (BMY) shares with a market value of roughly $4.00M accounting for 0.95% of the overall portfolio. To date, the estimated cost basis is nearly $54.37 for "buy" trades and estimated average "sell" price is $60.65. Miller Value Partners first purchased BMY in 2024 Q1, initially acquiring 60,000 shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Miller Value Partners has made 3 more transactions.
When did Bill Miller buy Bristol-Myers Squibb Company (BMY)?
Bill Miller first invested in Bristol-Myers Squibb Company (BMY) in 2024 Q1 at the reported quarter-end price of $54.23 per share.
What's the cost basis of Miller Value Partners's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $54.37 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $54.37
- Weighted AVG sell price:
- $60.65
Bill Miller's historical trades in Bristol-Myers Squibb Company
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.10%
|
69,500
|
$60.65
|
$4,215,175
|
-35.65% (-38,500)
|
-0.82%
|
|
2024 Q4
|
2.61%
|
108,000
|
$56.56
|
$6,108,480
|
+35.00% (+28,000)
|
+0.68%
|
|
2024 Q3
|
2.34%
|
80,000
|
$51.74
|
$4,139,200
|
+33.33% (+20,000)
|
+0.58%
|
|
2024 Q1
|
2.08%
|
60,000
|
$54.23
|
$3,253,800
|
new
|
+2.08%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.